Compositions and methods for joint health
US-11123393-B2 · Sep 21, 2021 · US
US9717770B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9717770-B2 |
| Application number | US-201514741221-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 16, 2015 |
| Priority date | Jun 16, 2014 |
| Publication date | Aug 1, 2017 |
| Grant date | Aug 1, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present disclosure provides mixtures of prenylated flavonoids, stilbenes, or both with flavans or curcuminoids or both capable of useful for promoting, managing or improving bone health, cartilage health or both, or for preventing or treating a bone disorder, cartilage disorder or both. Such a mixture of prenylated flavonoids, stilbenes, or both with flavans or curcuminoids or both can optionally be used in combination with other bone and cartilage management agents, such as calcium, magnesium, zinc, boron, vitamin D, vitamin K, glucosamine and/or chondroitin compounds, non-steroidal anti-inflammatory agents/analgesics, COX/LOX inhibiting agents, neuropathic pain relief agents, or the like.
Opening claim text (preview).
We claim: 1. A method for treating bone diseases, joint conditions and cartilage disorder in a mammal in need thereof consisting essentially of administering a therapeutically effective amount of a composition consisting essentially of a mixture of a Morus extract enriched for one or more prenylated flavonoids and one or more Stilbenes, and an Acacia extract enriched for flavans. 2. The method of claim 1 , wherein the Morus extract and the Acacia extract are blended in a 2:1 weight ratio. 3. The method of claim 1 , wherein the Morus extract is from Morus alba , and the Acacia extract is from Acacia catechu. 4. The method of claim 1 , wherein the Acacia extract comprises about 0.01% to about 99.9% of flavans. 5. The method of claim 1 , wherein the Morus extract comprises about 0.1% to about 49.9% prenylated flavonoids. 6. The method of claim 1 , wherein the Morus extract comprises about 0.1% to about 49.9% stilbenes.
Antineoplastic agents · CPC title
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] · CPC title
Centrally acting analgesics, e.g. opioids · CPC title
Muscle relaxants, e.g. for tetanus or cramps · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.